loader2
NRI

Dec 20, 2024

Category

Equity

AUM (Cr.)

1,213.92

Exit Load (%)

0.00

Min Inv Lumpsum

5,000

Expense Ratio

0.00

Sharpe Ratio

23.41

Beta Ratio

0.00

Fund Manager

Meeta Shetty

Inception Date

Dec 28, 2015

Risk Level

Very High

Investment Objective

To seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sector in India.

Invest Now
Nifty Pharma

Return Calculator

Investment Type

SIP Lumpsum

Company

  • periodic returns
  • Peer Comparison
Returns Type 1 Month (%) 6 Months (%) 1 Year (%) 3 Years (%) 5 Years (%) Since Inception (%)
Scheme - Tata India Pharma & Healthcare Fund (G) 4.59 17.7 42.34 22.77 27.39 13.34
Benchmark - Nifty Pharma 15.17 46.96 48.33 9.19 -2.27 0
Category Average - BEST EQUITY PERFORMERS 2.3 3.1 25.86 19.51 21.56 16.4
Category Rank 5/8 6/8 6/8 7/8 7/8 8/8
Fund Name Nav () Chg (%) 1Y Return(%) 3Y Return(%) 5Y Return(%) AUM ( in Crs) Exp. Ratio (%) Min.Invst() Action
Nippon India US Equity Opportunities Fund (G) 33.9996 0.82 21.03 8.89 14.14 719.18 2.39 100.00 invest
Nippon India US Equity Opportunities Fund (IDCW) 33.9996 0.82 21.03 8.89 14.14 719.18 2.39 100.00 invest
SBI Healthcare Opportunities Fund (G) 429.2021 0.37 42.39 25.37 29.37 3,459.68 1.95 5,000.00 invest
SBI Healthcare Opportunities Fund (IDCW) 270.3752 0.37 42.39 25.37 29.37 3,459.68 1.95 5,000.00 invest
Quant Teck Fund - Regular (G) 13.3489 -3.00 27.40 0.00 0.00 442.10 2.39 5,000.00 invest

Asset Allocation

Val (Cr.) Allocation (%)

Top sectors

AUM in Cr.

top holdings

Company Name As on Date Invested Amt (Cr) % Portfolio Weight Change (%)
(Invested Amt.)		 4 Months Trends
Equity-Sun Pharma.Inds. Nov 30, 2024 143.24 11.80 -3.68
Equity-Aurobindo Pharma Nov 30, 2024 93.56 7.71 -9.59
Equity-Lupin Nov 30, 2024 84.13 6.93 -6.23
Equity-Cipla Nov 30, 2024 75.16 6.19 -1.15
Equity-Dr Reddy`s Labs Nov 30, 2024 73.89 6.09 -5.64
Equity-Divi`s Lab. Nov 30, 2024 64.79 5.34 4.81
Equity-Fortis Health. Nov 30, 2024 56.37 4.64 5.52
Net CA & Others-Net CA & Others Nov 30, 2024 48.10 3.96 -23.77
Equity-Zydus Lifesci. Nov 30, 2024 45.52 3.75 -3.53
Equity-Alkem Lab Nov 30, 2024 42.46 3.50 -2.37

latest news

Tata MF announces change in Fund Manager of the following schemes

Tata Mutual Fund has announced change in Fund Managers of the following sch...

Dec 20, 2024 17:23

Tata MF announces Income Distribution cum capital withdrawal (IDCW) under two schemes

Tata Mutual Fund has announced 04 December 2024 as the record date for decl...

Dec 02, 2024 09:29

Tata MF launches index fund tracking India`s leading conglomerates

Tata Asset Management has launched the Tata BSE Select Business Group Index...

Nov 25, 2024 16:42

Tata MF launches Tata India Innovation Fund

Tata Mutual Fund has launched a new thematic fund, the Tata India Innovatio...

Nov 13, 2024 14:52

Tata MF announces Income Distribution cum capital withdrawal (IDCW) under two schemes

Tata Mutual Fund has announced 06 November 2024 as the record date for decl...

Nov 04, 2024 09:26

Tata AMC launches Nifty Capital Markets Index fund

Tata Mutual Fund has announced the launch of the Tata Nifty Capital Markets...

Oct 09, 2024 14:41

SCHEME DETAILS

AMC Name : Tata Mutual Fund
Fund Name : Tata India Pharma & Healthcare Fund (G)
Contact Persone : Meeta Shetty
Registered Address : 1903, B-Wing, Parinee Crescenzo,G-Block, Bandra Kurla Complex,Bandra East Mumbai - 400051
Telephone No : 022 62827777
Fax No. : 022 2261 3782.
Email : service:tataamc.com
Website : www.tatamutualfund.com